An apheresis procedure that removes the patient’s red blood cells and replaces them with healthy donor erythrocytes, used to treat conditions affecting red blood cell function or carrying intracellular pathogens.
Red blood cell exchange (erythrocytapheresis) is a specialized apheresis procedure that selectively removes the patient’s red blood cells and replaces them with compatible donor erythrocytes. Unlike simple transfusion, RBC exchange does not increase total blood volume or viscosity, making it safer for patients with conditions where volume overload is a concern.
This procedure is particularly valuable when the patient’s own red blood cells are dysfunctional, infected, or carry abnormal hemoglobin variants.
Blood is drawn from a venous access point and processed in an apheresis machine that separates red blood cells from plasma, white blood cells, and platelets. The patient’s red blood cells are removed and replaced with typed and crossmatched donor red blood cells. The patient’s own plasma and other blood components are returned.
The procedure can achieve replacement of 60-90% of the patient’s red blood cell mass in a single session, depending on the clinical goals. The process is automated and continuously monitored to maintain hemodynamic stability.
Red blood cell exchange is indicated for specific hematological and infectious conditions. Our physicians will evaluate your case and laboratory findings to determine suitability.
An RBC exchange session typically lasts 1.5-3 hours depending on the volume of cells being exchanged. The patient is seated comfortably with venous access established. The procedure is automated and monitored continuously for vital signs and hemodynamic parameters. Most patients tolerate the procedure well, with minimal discomfort beyond the initial venous access.
Red blood cell exchange is a well-established medical procedure with Category I (first-line) indications for sickle cell disease management according to the American Society for Apheresis guidelines. It is also an accepted treatment for severe parasitic infections affecting red blood cells. The procedure carries risks inherent to any blood transfusion, including allergic reactions and transfusion-related complications, which are minimized through careful donor matching and monitoring protocols.
Contact our medical team to discuss whether red blood cell exchange may be appropriate for your condition.
